Cognitive impairment in schizophrenia involves a broad array of nonsocial and social
cognitive domains. It is a core feature of the illness, and one with substantial implications for …

Introduction: Electrophysiological (EEG) abnormalities in subjects with schizophrenia have
been largely reported. In the last decades, research has shifted to the identification of …

Personalized medicine is rapidly becoming a reality in today's physical medicine. However,
as yet this is largely an aspirational goal in psychiatry, despite significant advances in our …

While the brain is ruled to a large extent by chemical neurotransmitters, it is also a bioelectric
organ. The collective study of Quantitative ElectroEncephaloGraphs (QEEG-the conversion …

In this article, we review clinical research using the mismatch negativity (MMN), a change-
detection response of the brain elicited even in the absence of attention or behavioural task …

Several attempts have been made to enhance N-methyl-D-aspartate (NMDA) receptor
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …

In an effort to reveal susceptibility genes, schizophrenia research has turned to the
endophenotype strategy. Endophenotypes are characteristics that reflect the actions of …

Cognition is often affected in a variety of neuropsychiatric, neurological, and
neurodevelopmental disorders. The neural discriminative response, reflected in mismatch …

Background Only about one third of patients at high risk for psychosis based on current
clinical criteria convert to a psychotic disorder within a 2.5-year follow-up period. Targeting …

Schizophrenia represents a pervasive deficit in brain function, leading to hallucinations and
delusions, social withdrawal and a decline in cognitive performance. As the underlying …